The PE Ratio as of December 2024 (TTM) for MediWound Ltd. (MDWD) is -6.15

According to MediWound Ltd.’s latest financial reports and current stock price. The company's current PE Ratio is -6.15. This represents a change of -9.19% compared to the average of -6.77 of the last 4 quarters.

MediWound Ltd. (MDWD) Historical PE Ratio (quarterly & annually)

How has MDWD PE Ratio performed in the past?

The mean historical PE Ratio of MediWound Ltd. over the last ten years is -13.93. The current -6.15 PE Ratio has changed 4.32% with respect to the historical average. Over the past ten years (40 quarters), MDWD's PE Ratio was at its highest in in the June 2023 quarter at 26.79. The PE Ratio was at its lowest in in the September 2019 quarter at -104.53.

MediWound Ltd. (MDWD) PE Ratio by Quarter and Year

Discovering the peaks and valleys of MediWound Ltd. PE Ratio, unveiling quarterly and yearly fluctuations to gain insights into the company’s financial performance and market dynamics, offering valuable data for investors and analysts alike.

MediWound Ltd. (MDWD) Average PE Ratio

How has MDWD PE Ratio performed in the past?

The current PE Ratio of MediWound Ltd. (MDWD) is greater than its 3-year, less than than its 5-year, and greater than its 10-year historical averages

MediWound Ltd. (MDWD) PE Ratio vs. Peers

How is MDWD’s PE Ratio compared to its peers?

MediWound Ltd.’s PE Ratio is less than Foghorn Therapeutics Inc. (-3.45), less than Eliem Therapeutics, Inc. (0), less than Sutro Biopharma, Inc. (-1.28), greater than Dyadic International, Inc. (-8.11), greater than Crinetics Pharmaceuticals, Inc. (-15.54), less than Inhibrx Biosciences, Inc. (0.14), greater than Merus N.V. (-11.84), less than Lyell Immunopharma, Inc. (-0.77), less than Kronos Bio, Inc. (-0.67), less than Aerovate Therapeutics, Inc. (-0.89), less than Keros Therapeutics, Inc. (-3.32), less than Syndax Pharmaceuticals, Inc. (-3.76), less than Mineralys Therapeutics, Inc. (-4.16), less than Replimune Group, Inc. (-4.61), greater than Ocular Therapeutix, Inc. (-7.98), greater than Veracyte, Inc. (-342.19), greater than Avidity Biosciences, Inc. (-13.79), greater than SpringWorks Therapeutics, Inc. (-9.94), less than Monte Rosa Therapeutics, Inc. (-4.84), less than Nkarta, Inc. (-1.56), less than Generation Bio Co. (-0.49), less than Sana Biotechnology, Inc. (-1.35),

Build a custom stock screener for MediWound Ltd. (MDWD) and other stocks

One of the best ways to find valuable stocks to invest in is to build a custom made screener in your Excel or Google Sheets spreadsheet. This allows you to compare thousands of companies like MediWound Ltd. using the financials and key metrics that matter to you in a single view.

The easiest way to set this up is to use the Wisesheets add-on and set your spreadsheet like this:

Covering all these metrics from financial, data, dividend data, key metrics and more you can get all the data you want for over 50+ exchanges worldwide.

Get your free trial here.

MediWound Ltd. (MDWD) and other stocks custom spreadsheet templates

The easiest way to analyze a company like MediWound Ltd. or any others is to create a spreadsheet model that automatically retrieves all of the stock data you need.

Using Wisesheets you can set up a spreadsheet model like this with simple spreadsheet formulas. If you change the ticker you can get all of the data automatically updated for you.

Whether you need live data, historical price data, financials, dividend data, key metrics, analyst estimates, or anything else...Wisesheets has you covered.